Pharmaguy's Insights Into Drug Industry News
185.8K views | +22 today
Follow
Pharmaguy's Insights Into Drug Industry News
Pharmaguy curates and provides insights into selected drug industry news and issues.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy
Scoop.it!

Just Because There's a Surge in Taxotere Lawsuit Filings, Does Not Mean the Cases Are Frivolous

Just Because There's a Surge in Taxotere Lawsuit Filings, Does Not Mean the Cases Are Frivolous | Pharmaguy's Insights Into Drug Industry News | Scoop.it

A recent, sudden surge in Taxotere lawsuit filings in the U.S. District Court of the Eastern District of Louisiana has caught Louisiana Lawsuit Abuse Watch's attention.

 

According to a news release from Schmidt National Law Group, the U.S. Judicial Panel on Multidistrict Litigation's Feb. 15 docket report shows 755 pending actions in the Taxotere litigation, up 50 from the panel's Jan. 17 report. Bernstein Liebhard LLP in New York reported in its Jan. 20 news release that the 705 pending actions as of Jan. 17, 2017, showed an increase of 443 pending actions in the Louisiana district since Dec. 16, 2016.

 

LLAW Executive Director Melissa Landry said the surge in lawsuits is a result of vigorous advertising by personal-injury attorneys.

 

Taxotere is a cancer medication that doctors use to treat breast, lung, prostate, stomach and head or neck cancer, according to drugs.com. The lawsuits allege Taxotere caused permanent hair loss.

 

Carrie Brown, the senior director of communications at Sanofi, the company that makes Taxotere, said in a December Louisiana Record story that the company has regularly provided safety information on Taxotere to the Food and Drug Administration.

 

According to the FDA website, the warning that cases of permanent hair loss had been reported showed up on Taxotere's label in the United States in December 2015. Brown said that the company made that change in December 2015 after the company spoke with the FDA.

 

Further Reading:

Pharma Guy's insight:

Did it take 5 years for Sanofi to report this problem? Back in 2005, I wrote this blog post: “Disgruntled Patient Shuts Down sanofi-aventis Facebook Page”; http://bit.ly/c83Ydr about Shirley Ledlie who claimed sanofi-aventis (S-A) mislead her about the side effects of cancer drug Taxotere.]

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Taxotere: A Chemo Drug Bringing More Suffering to Women’s Lives

Taxotere is an unnecessary chemo drug that is adding even more suffering to women’s lives. America’s Lawyer, Mike Papantonio, and attorney Ben Gordon discuss this.

Pharma Guy's insight:

"[These women] look like Ben Franklin!" I guess the lawyer being interviewed is representing patients harmed by taxotere in lawsuits. For more on this issue, read "sanofi aventis Feels the Social Media Pain"; http://bit.ly/SASMpain 

more...
No comment yet.